Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism

阐明果糖与胆固醇代谢之间的分子机制

基本信息

  • 批准号:
    10542839
  • 负责人:
  • 金额:
    $ 10.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2026-12-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY Fructose consumption is not only a major risk factor for development of non-alcoholic fatty liver disease (NAFLD), but also promotes hypercholesterolemia and atherosclerosis in humans and rodents. Identification of the mechanisms linking NAFLD to cardiovascular disease (CVD) remains poorly understand. This proposal focuses on identifying the influence dietary fructose has on synthesis and metabolism of cholesterol. Using a mouse model of sugar-sweetened beverage consumption, the candidate shows that fructose metabolism increases citrate, acetyl-CoA, and hepatic cholesterol levels. In addition, the candidate demonstrates fructose decreases the protein expression of carnitine palmitoyltransferase 1a (Cpt1a), a mitochondrial fatty acid transport protein. Moreover, conditional CPT1a knockout mice exhibit similar lipid perturbations as mice fed fructose. Therefore, aim 1 utilizes dual stable isotope techniques coupled with NMR and mass spectrometry to quantify cholesterol synthesis and fructose-derived carbon enrichment into the cholesterol biosynthetic pathway in male and female mice. Livers from the mice will be used for acetyl-proteomics to delineate potential mechanisms linking fructose to cholesterol biosynthesis. Aim 2 determines how transcriptional regulation of Cpt1a alters fructose-induced suppression of fatty acid oxidation and enhanced cholesterol synthesis using both in-vitro and in-vivo approaches. The purpose of this aim is to uncover a previous unrecognized role of Cpt1a in coordinating the regulation of both lipid-signaling pathways (fatty acid oxidation and cholesterol synthesis) in response to fructose. Completion of these aims will yield mechanistic insight linking dietary sugar metabolism to hypercholesterolemia. The novelty of the proposed research is the comprehensive dual-stable isotope approach in conjunction with analytical techniques to measure cholesterol synthesis and fructose-derived carbon enrichment into the sterol synthesis pathway in the same cohort of animals. In addition, the proposed research reveals several innovative mechanisms that have yet to be explored, including acetylation of cholesterol synthesis enzymes and regulation of Cpt1a through transcriptional mechanisms. Strong collaborations among the Metabolomics Core at the University of Kentucky, Mass Spectrometry Core at the Buck Institute for Research on Aging, and scientific advisory committee members ensure successful completion of the proposed research by the candidate. This research is complimented by a career development plan in which the candidate will learn new experimental methodology in stable isotope metabolomics, broaden his scientific network through attending workshops and conferences, and develop his communication skills so that he is poised to become an independent investigator. This K01 award will allow him to reach his long-term goals of establishing a well-funded laboratory studying dietary mechanisms in cardiometabolic disease.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Nathaniel Helsley其他文献

Robert Nathaniel Helsley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Nathaniel Helsley', 18)}}的其他基金

Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism
阐明果糖与胆固醇代谢之间的分子机制
  • 批准号:
    10367780
  • 财政年份:
    2022
  • 资助金额:
    $ 10.05万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 10.05万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了